| Identification | Back Directory | [Name]
(2s)-2-[[6-[(3-CHLORO-4-CARBOXYPHENYL)AMINO]-9-(1-METHYLETHYL)-9H-PURIN-2-YL]AMINO]-3-METHYL-1-BUTANOL | [CAS]
2310135-61-4 | [Synonyms]
(2s)-2-[[6-[(3-CHLORO-4-CARBOXYPHENYL)AMINO]-9-(1-METHYLETHYL)-9H-PURIN-2-YL]AMINO]-3-METHYL-1-BUTANOL | [Molecular Formula]
C20H25ClN6O3 | [MOL File]
2310135-61-4.mol | [Molecular Weight]
432.9 |
| Chemical Properties | Back Directory | [Boiling point ]
660.6±65.0 °C(predicted) | [density ]
1.43±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | [form ]
Solid | [pka]
2.81±0.25(predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
(S)-Purvalanol B is the S enantiomer of Purvalanol B. Purvalanol B is a cyclin-dependent kinase inhibitor. | [References]
[1] Bullard KM, Effects of cyclin-dependent kinase inhibitor Purvalanol B application on protein expression and developmental progression in intra-erythrocytic Plasmodium falciparum parasites. Malar J. 2015 Apr 8;14:147. DOI:10.1186/s12936-015-0655-x |
|
|